Found: 538
Select item for more details and to access through your institution.
Infectious and immunological sequelae of daratumumab in multiple myeloma.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 187, doi. 10.1111/bjh.15433
- By:
- Publication type:
- Article
Nanosecond Dynamics Regulate the MIF‐Induced Activity of CD74.
- Published in:
- Angewandte Chemie, 2018, v. 130, n. 24, p. 7234, doi. 10.1002/ange.201803191
- By:
- Publication type:
- Article
IL-6 is associated to IGF-1Ec upregulation and Ec peptide secretion, from prostate tumors.
- Published in:
- Molecular Medicine, 2018, v. 24, n. 1, p. 1, doi. 10.1186/s10020-018-0003-z
- By:
- Publication type:
- Article
Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4 T cells from patients with GI malignancy.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1269, doi. 10.1007/s00262-011-1029-z
- By:
- Publication type:
- Article
Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1289, doi. 10.1007/s00262-011-1033-3
- By:
- Publication type:
- Article
Therapeutic effects of metformin in breast cancer: involvement of the immune system?
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1221, doi. 10.1007/s00262-011-1062-y
- By:
- Publication type:
- Article
Lung cancer and Toll-like receptors.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1211, doi. 10.1007/s00262-011-1057-8
- By:
- Publication type:
- Article
Tenth International Conference on Progress in Vaccination Against Cancer (PIVAC 10), Cambridge, UK, 27th-30th September 2010: New hopes and strategies for cancer vaccines.
- Published in:
- 2011
- By:
- Publication type:
- Report
Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1127, doi. 10.1007/s00262-011-0985-7
- By:
- Publication type:
- Article
Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 4, p. 525, doi. 10.1007/s00262-010-0961-7
- By:
- Publication type:
- Article
NFAT1 transcription factor is central in the regulation of tissue microenvironment for tumor metastasis.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 4, p. 537, doi. 10.1007/s00262-010-0964-4
- By:
- Publication type:
- Article
Effective adoptive therapy of tap-deficient lymphoma using diverse high avidity alloreactive T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 4, p. 629, doi. 10.1007/s00262-009-0805-5
- By:
- Publication type:
- Article
Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 4, p. 619, doi. 10.1007/s00262-009-0814-4
- By:
- Publication type:
- Article
Functional CD8<sup>+</sup> T cells infiltrate into nonsmall cell lung carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 587, doi. 10.1007/s00262-006-0214-y
- By:
- Publication type:
- Article
HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 709, doi. 10.1007/s00262-006-0226-7
- By:
- Publication type:
- Article
Vaccination against prostate cancer using a live tissue factor deficient cell line in Lobund–Wistar rats.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 725, doi. 10.1007/s00262-006-0223-x
- By:
- Publication type:
- Article
Metronomic cyclophosphamide regimen selectively depletes CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells and restores T and NK effector functions in end stage cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 641, doi. 10.1007/s00262-006-0225-8
- By:
- Publication type:
- Article
Ii-Key/HER-2/ neu(776–790) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/ neu+ tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 601, doi. 10.1007/s00262-006-0213-z
- By:
- Publication type:
- Article
Phase II study of interleukin-2 and 13- cis-retinoic acid as maintenance therapy in metastatic colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 699, doi. 10.1007/s00262-006-0224-9
- By:
- Publication type:
- Article
Costimulation tunes tumor-specific activation of redirected T cells in adoptive immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 731, doi. 10.1007/s00262-006-0249-0
- By:
- Publication type:
- Article
Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 739, doi. 10.1007/s00262-006-0272-1
- By:
- Publication type:
- Article
Robert Baldwin: 50 years of cancer immunology.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Tumor immune escape mechanisms: impact of the neuroendocrine system.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 7, p. 749, doi. 10.1007/s00262-006-0126-x
- By:
- Publication type:
- Article
International symposium on tumour escape and its determinants: meeting report.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 2, p. 229, doi. 10.1007/s00262-005-0034-5
- By:
- Publication type:
- Article
Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: Therapeutic effect against cervical cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 12, p. 1180, doi. 10.1007/s00262-005-0685-2
- By:
- Publication type:
- Article
A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 12, p. 1172, doi. 10.1007/s00262-005-0686-1
- By:
- Publication type:
- Article
CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 12, p. 1162, doi. 10.1007/s00262-005-0682-5
- By:
- Publication type:
- Article
<sup>90</sup>Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 12, p. 1200, doi. 10.1007/s00262-005-0693-2
- By:
- Publication type:
- Article
A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 12, p. 1214, doi. 10.1007/s00262-005-0705-2
- By:
- Publication type:
- Article
Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 826, doi. 10.1007/s00262-004-0650-5
- By:
- Publication type:
- Article
Expression of STAT1 and STAT2 in malignant melanoma does not correlate with response to interferon-alpha adjuvant therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 815, doi. 10.1007/s00262-004-0649-y
- By:
- Publication type:
- Article
Role of tumor-derived transforming growth factor-β1 (TGF-β1) in site-dependent tumorigenicity of murine ascitic lymphosarcoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 837, doi. 10.1007/s00262-004-0656-z
- By:
- Publication type:
- Article
Phase I study of TNFα AutoVaccIne in Patients with metastatic cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 848, doi. 10.1007/s00262-005-0661-x
- By:
- Publication type:
- Article
Heat shock protein 70/MAGE-3 fusion protein vaccine can enhance cellular and humoral immune responses to MAGE-3 in vivo.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 907, doi. 10.1007/s00262-004-0660-3
- By:
- Publication type:
- Article
Sustained low-level expression of interferon-γ promotes tumor development: potential insights in tumor prevention and tumor immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 891, doi. 10.1007/s00262-004-0654-1
- By:
- Publication type:
- Article
Exposure to the electrofusion process can increase the immunogenicity of human cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 880, doi. 10.1007/s00262-004-0659-9
- By:
- Publication type:
- Article
Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 915, doi. 10.1007/s00262-004-0638-1
- By:
- Publication type:
- Article
Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 858, doi. 10.1007/s00262-004-0646-1
- By:
- Publication type:
- Article
Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 926, doi. 10.1007/s00262-005-0677-2
- By:
- Publication type:
- Article
Antibody-mediated targeting of human single-chain class I MHC with covalently linked peptides induces efficient killing of tumor cells by tumor or viral-specific cytotoxic T lymphocytes.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 867, doi. 10.1007/s00262-005-0666-5
- By:
- Publication type:
- Article
Transforming growth factor-β<sub>1</sub> immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 898, doi. 10.1007/s00262-004-0652-3
- By:
- Publication type:
- Article
Beneficial therapeutic effects with different particulate structures of murine polyomavirus VP1-coat protein carrying self or non-self CD8 T cell epitopes against murine melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 6, p. 611, doi. 10.1007/s00262-004-0655-0
- By:
- Publication type:
- Article
Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 6, p. 599, doi. 10.1007/s00262-004-0635-4
- By:
- Publication type:
- Article
A listing of human tumor antigens recognized by T cells: March 2004 update.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 3, p. 187, doi. 10.1007/s00262-004-0560-6
- By:
- Publication type:
- Article
Biodistributions of intact monoclonal antibodies and fragments of BLCA-38, a new prostate cancer directed antibody.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 6, p. 533, doi. 10.1007/s00262-003-0460-1
- By:
- Publication type:
- Article
A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 6, p. 497, doi. 10.1007/s00262-003-0465-9
- By:
- Publication type:
- Article
Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D<sub>3</sub>.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 5, p. 422, doi. 10.1007/s00262-003-0459-7
- By:
- Publication type:
- Article
Modulation of costimulation to enhance tumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 663, doi. 10.1007/s00262-003-0424-5
- By:
- Publication type:
- Article
International conference: Progress in vaccination against cancer (PIVAC) 2002, Nottingham, UK.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 6, p. 403, doi. 10.1007/s00262-002-0366-3
- By:
- Publication type:
- Article
The mechanism of regression of solid SL2 lymphosarcoma after local IL-2 therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 9, p. 492, doi. 10.1007/s00262-002-0306-2
- By:
- Publication type:
- Article